search
Back to results

Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia

Primary Purpose

Hypotension

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
Dexamethasone
Placebo
Sponsored by
Ain Shams University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypotension

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. American Society of Anesthesiologists (ASA) Physical Status Class-I and II.
  2. Elective surgery under general anesthesia.

Exclusion Criteria:

  1. Emergency surgeries.
  2. Ischemic heart disease.
  3. Peptic ulcer & active infection.
  4. Psychiatric disorder.
  5. Patients on steroids or serotonin related medications (e.g., selective serotonin reuptake inhibitor).

Sites / Locations

  • Ain-Shams University Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

D Group (50 patients)

C Group (50 patients)

Arm Description

Outcomes

Primary Outcome Measures

The proportion of patients with hypotension (25% decrease below the baseline for mean blood pressure (mmHg).
The proportion of patients with hypotension (25% decrease below the baseline for mean blood pressure (mmHg).

Secondary Outcome Measures

Full Information

First Posted
May 27, 2021
Last Updated
October 21, 2021
Sponsor
Ain Shams University
search

1. Study Identification

Unique Protocol Identification Number
NCT04908592
Brief Title
Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia
Official Title
Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
June 15, 2021 (Actual)
Primary Completion Date
September 15, 2021 (Actual)
Study Completion Date
September 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Geriatric patients who undergo general anesthesia experience post induction hypotension which is treated with intravenous fluids and ephedrine. The main cause of post-induction hypotension is the decrease in the sympathetic outflow causing arterial vasodilatation, a decrease in venous return and consequently the activation of the Bezold Jarish reflex (BJR) that elicits a triad of bradycardia, vasodilatation and further hypotension. BJR is elicited by activation of 5-HT3 receptors within the intracardiac vagal nerve endings. Glucocorticoids in general inhibit 5-HT3 expression and dexamethasone was found to decrease the level of 5-HT3 in the cerebral cortex and hippocampus in developing rats. So, the research team hypothesizes that dexamethasone can attenuate the postinduction hypotension in geriatric patients undergoing general anesthesia if administered preoperatively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
D Group (50 patients)
Arm Type
Active Comparator
Arm Title
C Group (50 patients)
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Intervention Description
Patients will receive dexamethasone 8 mg diluted in 100 ml 0.9% normal saline (NS) IVI over 15 min 2 h preoperatively.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Patients will receive 100 ml 0.9% normal saline (NS) IVI over 15 min 2 h preoperatively.
Primary Outcome Measure Information:
Title
The proportion of patients with hypotension (25% decrease below the baseline for mean blood pressure (mmHg).
Description
The proportion of patients with hypotension (25% decrease below the baseline for mean blood pressure (mmHg).
Time Frame
intraoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists (ASA) Physical Status Class-I and II. Elective surgery under general anesthesia. Exclusion Criteria: Emergency surgeries. Ischemic heart disease. Peptic ulcer & active infection. Psychiatric disorder. Patients on steroids or serotonin related medications (e.g., selective serotonin reuptake inhibitor).
Facility Information:
Facility Name
Ain-Shams University Hospitals
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Dexamethasone in Attenuation of Postinduction Hypotension in Geriatric Patients Undergoing General Anesthesia

We'll reach out to this number within 24 hrs